BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 26481591)

  • 1. Ioxaglate Versus IoDixanol for the Prevention of Contrast-Induced Nephropathy: The IDPC Trial.
    Freitas RAP; Tanajura LF; Mehran R; Chamié D; Chaves A; Centemero M; Braga S; Costa R; Cao D; Sousa A; Feres F; Costa JR
    J Invasive Cardiol; 2023 Jun; 35(6):E281-E290. PubMed ID: 37220640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iso-osmolar vs low-osmolar contrast agents for coronary optical coherence tomography: a blinded prospective randomized controlled study.
    Kostantinis S; Mastrodemos O; Stanberry L; Sandoval Y; Allana SS; Mutlu D; Simsek B; Rempakos A; Karacsonyi J; Alexandrou M; Okeson BK; Burke MN; Rangan BV; Brilakis ES
    J Invasive Cardiol; 2024 Jun; 36(6):. PubMed ID: 38446023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetylcysteine does not prevent contrast induced nephropathy after cardiac catheterisation with an ionic low osmolality contrast medium: a multicentre clinical trial.
    Gomes VO; Poli de Figueredo CE; Caramori P; Lasevitch R; Bodanese LC; Araújo A; Röedel AP; Caramori AP; Brito FS; Bezerra HG; Nery P; Brizolara A
    Heart; 2005 Jun; 91(6):774-8. PubMed ID: 15894775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different outcomes between iso-osmolar and low-osmolar contrast media in acute myocardial infarction with renal impairment.
    Oh S; Kim JS; Ahn Y; Ahn JH; Hyun DY; Lee SH; Cho KH; Kim MC; Sim DS; Hong YJ; Kim JH; Jeong MH
    Cardiol J; 2023; 30(5):790-798. PubMed ID: 34931692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of invasive cardiac procedures after acute myocardial infarction in long-term dialysis patients.
    Charytan D; Mauri L; Agarwal A; Servoss S; Scirica B; Kuntz RE
    Am Heart J; 2006 Sep; 152(3):558-64. PubMed ID: 16923431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosing of iodixanol for predicting acute kidney injury in patients undergoing elective percutaneous coronary intervention.
    Chen Z; Zhao N; Zhang Y; Zhao R; Zhao X
    Eur J Intern Med; 2023 Dec; 118():136-138. PubMed ID: 37679280
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of contrast agent viscosity on coronary balloon deflation times: bench testing results.
    Mogabgab O; Patel VG; Michael TT; Kotsia A; Christopoulos G; Banerjee S; Brilakis ES
    J Interv Cardiol; 2014 Apr; 27(2):177-81. PubMed ID: 24450393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute kidney injury post coronary angioplasty.
    Naik SM; Shukla S; Sethi J; Sekar A
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35236711
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute Kidney Injury Risk Prediction in Patients Undergoing Coronary Angiography in a National Veterans Health Administration Cohort With External Validation.
    Brown JR; MacKenzie TA; Maddox TM; Fly J; Tsai TT; Plomondon ME; Nielson CD; Siew ED; Resnic FS; Baker CR; Rumsfeld JS; Matheny ME
    J Am Heart Assoc; 2015 Dec; 4(12):. PubMed ID: 26656858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Iodixanol in Computed Coronary Tomographic Angiography and Cardiac Catheterization.
    Budoff MJ; Lee HS; Roy SK; Shekar C
    J Cardiovasc Dev Dis; 2023 Oct; 10(11):. PubMed ID: 37998507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary Artery Bypass Grafting in Patients with Chronic Kidney Disease: Chronic Kidney Disease Has an Independent Adverse Effect on the Long-Term Outcome of Coronary Artery Bypass Grafting.
    Endo D; Yamamoto T; Kajimoto K; Matsushita S; Dohi S; Shimada A; Yokoyama Y; Io H; Suzuki Y; Tabata M; Amano A
    Biomed Res Int; 2022; 2022():4994970. PubMed ID: 35528157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effect of iso-osmolar versus low-osmolar contrast media on the incidence of contrast-induced acute kidney injury in diabetic patients: a systematic review and meta-analysis.
    Zhao F; Lei R; Yang SK; Luo M; Cheng W; Xiao YQ; Li XW; Guo J; Duan SB
    Cancer Imaging; 2019 Jun; 19(1):38. PubMed ID: 31215488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute kidney injury following coronary angiography: a nationwide study of incidence, risk factors and long-term outcomes.
    Helgason D; Long TE; Helgadottir S; Palsson R; Sigurdsson GH; Gudbjartsson T; Indridason OS; Gudmundsdottir IJ; Sigurdsson MI
    J Nephrol; 2018 Oct; 31(5):721-730. PubMed ID: 30187381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-year results of the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study.
    Giustino G; Baber U; Mastoris I; Vlachojannis GJ; Yu J; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Nikolsky E; Wong SC; Theodoropoulos KN; Dangas GD; Mehran R
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):703-9. PubMed ID: 26481591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.
    Mehran R; Nikolsky E; Kirtane AJ; Caixeta A; Wong SC; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Kim YH; Fahy M; Dangas GD
    JACC Cardiovasc Interv; 2009 May; 2(5):415-21. PubMed ID: 19463464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
    Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: A multicenter, randomized, double-blind study. Visipaque in Percutaneous Transluminal Coronary Angioplasty [VIP] Trial Investigators.
    Bertrand ME; Esplugas E; Piessens J; Rasch W
    Circulation; 2000 Jan; 101(2):131-6. PubMed ID: 10637198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials.
    Reed M; Meier P; Tamhane UU; Welch KB; Moscucci M; Gurm HS
    JACC Cardiovasc Interv; 2009 Jul; 2(7):645-54. PubMed ID: 19628188
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.